C反应蛋白在诊断妊娠合并子宫肌瘤退行性变中的意义  

Signification of C-reactive protein in the diagnosis of pregnancy associated with hysteromyoma degeneration

作　　者：黄欣慰[1] 朱韫春[1] 

机构地区：[1]南京市妇幼保健院产科二病区,江苏南京210004

出　　处：《中国肿瘤外科杂志》2011年第6期357-359,共3页Chinese Journal of Surgical Oncology

摘　　要：目的通过监测妊娠合并子宫肌瘤患者的C反应蛋白(CRP)水平,评价其对妊娠期子宫肌瘤退行性变的诊疗价值。方法选择妊娠合并子宫肌瘤42例作为研究对象,将有临床症状的妊娠合并子宫肌瘤退行性变患者22例作为研究组,将妊娠合并子宫肌瘤但无退行性变20例作为对照组,对比两组的C反应蛋白值情况。结果研究组CRP值为(22.06±10.96)mg/L,对照组CRP值为(3.79±1.58)mg/L,两组之间差异有统计学意义(P<0.05)。结论监测CRP对早期诊断妊娠合并子宫肌瘤退行性变有重要意义。Objective Through monitoring the C-reactive protein （CRP） level of pregnancy associated with hysteromyoma, we evaluate the value of C-reactive protein （CRP） level for the diagnosis and treatment of the pregnancy associated with hysteromyoma degeneration. Methods 42 cases of pregnancy associated with hysteromyomas as subjects, 22 cases of the patients that had clinical symptoms of pregnancy associated with hystero- myoma degeneration belonged to research group,20 cases of the pregnancy associated with hysteromyoma but no degeneration belonged to control group, compared to the C-reactive protein values of these two groups. Results The CRP value of the research group was（ 22.06 ± 10.96 ） mg/L, that of the control group was（ 3.79 ± 1.58 ） mg/L, the difference between the two groups was statistically significant （ P 〈 0.05 ）. Conclusions Monitoring of CRP on early diagnosis of pregnancy associated with hysteromyoma degeneration is important.

关 键 词：C反应蛋白 妊娠 子宫肌瘤 子宫肌瘤退行性变 诊断 

分 类 号：R737.33[医药卫生—肿瘤]